Pharma & Life Sciences · Switzerland
Marketing and digital systems for pharma and life sciences in Switzerland
Switzerland is a global life sciences hub with strict rules on medicines advertising: prescription medicines cannot be advertised to the public, professional advertising must be accurate and balanced, and industry codes govern cooperation with healthcare professionals. Communication must work in several languages.
Switzerland’s life sciences sector includes some of the world’s largest pharmaceutical companies, alongside biotech start-ups, medtech firms, contract research organisations and suppliers. Swissmedic authorises and supervises therapeutic products, and the Therapeutic Products Act and its advertising ordinance set out what companies may say about medicines.
Digital communication in this sector must balance scientific accuracy, regulatory compliance and multilingual audiences. Healthcare professionals expect precise, evidence-based information in German, French or Italian, patients need clear disease awareness content that does not become advertising for prescription medicines, and investors and talent look for credible corporate communication in English.
The rules that change the work in Switzerland
- No public advertising of prescription medicines
- Advertising prescription-only medicines to the public is prohibited in Switzerland. Patient content must focus on disease awareness without promoting specific prescription products.
- Advertising to professionals
- Advertising to healthcare professionals must be accurate, balanced, scientifically supported and consistent with the approved product information.
- Industry codes
- Swiss industry codes govern promotion and cooperation with healthcare professionals and organisations, including transparency of transfers of value.
- Medical devices
- Medical devices sold in Switzerland must meet Swiss medical device rules, including requirements for authorised representatives for foreign manufacturers.
- Human research
- Clinical research involving people follows Swiss human research law and ethics approval, which affects recruitment and trial communication.
- Swiss data protection
- Personal data, including health data, falls under the revised Federal Act on Data Protection, supervised by the FDPIC.
This describes how we scope and build. It is not legal advice: rules change and their application depends on your circumstances, so confirm with a lawyer qualified in Switzerland.
How the sector looks in Switzerland
Basel is Switzerland’s pharmaceutical centre, Zurich has strong biotech and medtech clusters, and the Lake Geneva region hosts life sciences companies and research institutions. Swiss companies export medicines and medical technology worldwide.
The sector competes for talent, partnerships and investment internationally, so English corporate communication matters alongside local-language professional and patient content. Digital channels for healthcare professionals, medical education and scientific engagement continue to grow.
What works here
- Healthcare professional portals
- Secure access to product information and education for professionals.
- Disease awareness content
- Patient information that does not promote prescription medicines.
- Scientific communication
- Publications, congress content and medical education.
- Employer branding
- Talent attraction for scientific and technical roles.
- Investor communication
- Clear updates for investors and partners.
Typical projects
- Professional access portal
- Login-protected information for healthcare professionals.
- Promotional review workflow
- Medical, legal and regulatory review of materials.
- Multilingual product information
- Accurate content in German, French and Italian.
- Clinical trial recruitment pages
- Ethics-approved trial information.
- FADP-compliant data handling
- Consent and data protection for professional and patient data.
Where it goes wrong
The most common mistake is patient content that becomes promotion of prescription medicines.
The second is professional materials that exceed approved product information.
The third is weak review processes for digital and social media content.
Finally, inconsistent translations across Swiss languages.
Questions
How should Swiss pharma companies manage social media?
With clear rules on who may post, medical and regulatory review of content, processes for handling adverse event reports and comments, and care that posts visible to the public never promote prescription medicines.
Can Swiss life sciences companies share clinical trial results online?
They can publish scientific and trial information in an appropriate, balanced way, but communication to the public must not become promotion of prescription medicines, so context, audience and wording need careful review.
What makes a good healthcare professional portal in Switzerland?
Reliable verification of professional status, accurate product information in the right language, useful education and services, clear privacy information and content that medical and regulatory teams can keep current.
How do Swiss biotech start-ups use digital marketing?
Mainly for investor relations, partnering, recruitment and scientific credibility, through clear websites, publications, conference presence and LinkedIn, rather than product advertising before approval.
Can prescription medicines be advertised to the public in Switzerland?
No. Public advertising of prescription-only medicines is prohibited.
Who regulates medicines in Switzerland?
Swissmedic authorises and supervises therapeutic products.
What rules apply to advertising to healthcare professionals?
It must be accurate, balanced, scientifically supported and consistent with approved product information.
Do Swiss pharma companies follow industry codes?
Yes. Industry codes govern promotion and cooperation with healthcare professionals.
Which languages are needed for Swiss pharma communication?
German, French and Italian for local audiences, and English for international communication.
What is disease awareness content?
Information about conditions and care that does not promote specific prescription medicines.
Do medical devices have separate rules?
Yes. Medical devices follow Swiss medical device regulations.
How should health data be handled?
Under the revised Federal Act on Data Protection with strong security.
Where are Swiss life sciences clusters?
Basel, Zurich and the Lake Geneva region are major clusters.
Related guides
Talk to us about pharma & life sciences in Switzerland
Tell us what you are trying to change. We will say what the rules allow, where the work should start, and whether we are the right team for it.
Get in touch